ArticleThe Angle orthodontist2025
Skeletal and dental effects of a new compliance-free appliance, the NET3 corrector, in management of skeletal Class III malocclusion compared to rapid maxillary expansion-facemask.
Article in The Angle orthodontist, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Therapeutic Approaches Dealing with Malocclusion Type III-Narrative Review.Life (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo examine retrospectively the short-term effects of a compliance-free skeletal Class III corrector (NET3-corrector) compared to rapid maxillary expansion-facemask (RME-FM). MATERIAL AND
methodsRecords of 20 skeletal Class III patients treated with the NET3-corrector were compared to 20 patients treated with RME-FM, mean age: 11.14 ± 1.17 years and 11.14 ± 2.06, respectively. The NET3-corrector consisted of a hybrid-expander, a lower lingual arch, and a modified PowerScope spring. The RME-FM group received an RME-facemask combination. T2 records were collected when an overjet of at least 2 mm was achieved. Differences between two timepoints within groups and differences between groups were tested using paired samples t-test and independent samples t-test, respectively (P < .05 was considered statistically significant).
resultsThe treatment time was 10.5 months with NET3-corrector and 12 months with RME-FM. The NET3-corrector was well tolerated by patients and the Class III malocclusion was corrected in all patients in both groups. The overall maxillary skeletal change was greater with the NET3-corrector, with an additional 2° advancement at SNA (P < .001). Significant differences in maxillary incisor angulation were observed in the RME-FM group in comparison to NET3 (-0.37 ± 3.31 vs 4.96 ± 3.80; P < .001). The mandibular molars tipped significantly more distally in the NET3 group (7.3° more; P < .001).
conclusionsThe compliance-free tooth-bone-borne NET3-corrector, is effective in correcting Class III malocclusion with improved maxillary skeletal outcomes compared to RME-FM in the short term. These results need to be evaluated in the long term with a randomized sample.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.